CAS 366789-02-8 | Rivaroxaban

Rivaroxaban (CAS 366789-02-8)

Product Overview

Rivaroxaban is an oxazolidinone-based small molecule functioning as a direct, oral Factor Xa inhibitor. Supplied as a high-purity active pharmaceutical ingredient (API) and reference standard, this compound selectively blocks free and clot-bound Factor Xa to regulate thrombin generation without requiring cofactors.

Applications

• Coagulation Pathway Research: Utilized in biochemical assays to study direct Factor Xa inhibition and prothrombinase complex kinetics.
• Antithrombotic & Cardiovascular Studies: Researched in preclinical models for venous thromboembolism (VTE) prevention and stroke prophylaxis in atrial fibrillation.
• Pharmaceutical Formulation & Testing: Applied as an active ingredient standard in oral solid dose development, bioequivalence, and dissolution profiling.
• Analytical Reference Standard: Employed in HPLC, LC-MS, and quality control procedures for purity verification and impurity profiling.

Storage & Handling

• Store in a tightly closed container in a dry, cool, and well-ventilated place.
• Recommended storage temperature: 2°C to 8°C (or room temperature, tightly sealed).
• Protect from ambient moisture, excessive heat, and direct exposure to light.

Synonyms & Identifiers

Rivaroxaban | BAY 59-7939 | Xarelto | CAS 366789-02-8 | EINECS 685-132-2 | MDL MFCD11974010